Secondary Logo

Journal Logo

Brief Report

Stigma and HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART

Hoffman, Susie DrPH*,†; Tymejczyk, Olga MPH‡,§; Kulkarni, Sarah MPH‡,§; Lahuerta, Maria PhD, MPH†,‖; Gadisa, Tsigereda MD; Remien, Robert H. PhD*; Melaku, Zenebe MD; Nash, Denis PhD, MPH*,†,‡,§; Elul, Batya PhD, MSc†,‖

JAIDS Journal of Acquired Immune Deficiency Syndromes: December 1, 2017 - Volume 76 - Issue 4 - p 382–387
doi: 10.1097/QAI.0000000000001530
Epidemiology
Free

Background: Stigma harms the mental health of HIV-positive individuals and reduces adherence to antiretroviral therapy (ART), but less is known about stigma and other outcomes across the HIV care continuum.

Methods: Among 1180 Ethiopian adults initiating ART at 6 urban HIV clinics, we examined the relationship of internalized, anticipated, and enacted stigma to HIV care-related outcomes ascertained by interview (repeat HIV-positive testing, provider vs. self-referred testing, missed clinic visit before ART initiation, eagerness to begin ART), and by abstraction of routinely collected clinical data (late ART initiation, 3-month gap in care following ART initiation). Logistic regression was used to assess the association of each type of stigma with each outcome, adjusting for potential confounders.

Results: Scoring higher on each stigma domain was associated with 50%–90% higher odds of repeat HIV-positive testing. High internalized stigma was associated with higher odds of provider vs. self-referred test [adjusted odds ratio (aOR)high vs. low: 1.7; 95% confidence interval (CI): 1.3 to 2.2]. Higher anticipated stigma was associated with lower eagerness to begin ART (aORhigh vs. low: 0.55; 0.35–0.87; aORmedium vs. low: 0.45; 95% CI: 0.30 to 0.69). Any enacted stigma was associated with higher odds of a missed visit (aORany vs. none 1.8; 1.2–2.8). Stigma was not associated with late ART-initiation or with a subsequent gap in care.

Discussion and Conclusions: These findings provide further evidence of the importance of measuring and addressing stigma across the entire care continuum. Future work should test hypotheses about specific stigma domains and outcomes in prospective intervention or observational studies.

*HIV Center for Clinical and Behavioral Studies at the NYS Psychiatric Institute and Columbia University, New York City, NY;

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, NY;

Graduate School of Public Health and Health Policy, City University of New York, New York, NY;

§Institute of Implementation Science in Population Health, City University of New York, New York, NY; and

ICAP, Columbia University Mailman School of Public Health, New York City, NY.

Correspondence to: Susie Hoffman, DrPH, HIV Center for Clinical and Behavioral Studies, 1051 Riverside Drive, Unit 15, New York, NY 10032 774-6955 (e-mail: sh51@cumc.columbia.edu).

Supported by PEPFAR and by a grant from the National Institute of Mental Health (Grant number R01MH089831, B.E., Principal Investigator, D.N., Co-Principal Investigator). All clinics included in this analysis received support from ICAP through funding from PEPFAR. The HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University (S.H., R.H.R., and D.N.) is supported by a center grant from the National Institute of Mental Health [P30-MH43520; Principal Investigators: Anke A. Ehrhardt (1987–2013)/R.H.R. (2013–2018)].

The authors have no conflicts of interest to disclose.

Received March 17, 2017

Accepted August 14, 2017

Back to Top | Article Outline

INTRODUCTION

Thirty years into the HIV/AIDS epidemic, HIV-related stigma remains an ongoing challenge and a growing priority for intervention.1,2 People living with HIV (PLWH) who experience high perceptions of HIV-related stigma are less likely to disclose their status3–5; they report more psychological distress6,7 and lower social support8,9 than those with lower perceptions of HIV-related stigma. Stigma also has been associated with some outcomes along the HIV care continuum. Those who hold more stigmatizing attitudes toward PLWH are less likely to undergo HIV testing themselves,10–15 and high perceived stigma among those in HIV care is associated with poorer antiretroviral therapy (ART) adherence.16 However, evidence on whether stigma influences other care continuum outcomes is limited.17–23

As conceptualized by Earnshaw and Chaudoir,24 stigma processes and outcomes differ between PLWH, who may experience stigma around being HIV-infected, and those who are HIV-negative (or do not know their status), who may hold stigmatizing views of PLWH. Among PLWH, stigma comprises 3 domains—internalized, anticipated, and enacted stigma. Few studies have examined the relationship of each of these domains to care-related outcomes. Understanding how stigma processes may influence outcomes across the HIV care continuum is important for guiding interventions to achieve the UNAIDS 90-90-90 targets, especially in sub-Saharan Africa, where significant gaps have been reported.25–27

We used data from Ethiopian adults newly initiating ART to explore associations between stigma and important care-related outcomes. We hypothesized that higher stigma would be associated with indicators of delay in HIV testing and/or care enrollment/ART initiation, and sporadic use of care once enrolled/initiated on ART.

In Ethiopia, HIV prevalence declined between 2005 to 2013 (estimated 1.2% in adults), but in 2013 there were still 590,000 adult PLWH, only 50% of whom were receiving ART.28 HIV stigma indicators in 2011 were in the mid-range of sub-Saharan countries, with 17.1% of women and 27.6% men holding stigmatizing views.29

Back to Top | Article Outline

METHODS

Participants and Data Sources

Data were drawn from a cross-sectional and prospective study of late initiation of ART described previously.30 PLWH ≥18 years of age newly initiating ART between June 2012 and April 2013 at 6 HIV clinics in Oromia, Ethiopia, were eligible for inclusion. The sites were secondary health facilities in urban areas and receiving support from ICAP at Columbia University with funding from the U.S. President's Emergency Plan for AIDS Relief.

Clinic providers referred eligible patients to study staff on the day of ART initiation. Those interested in study participation provided written informed consent and completed a 45-minute structured interview within 2 weeks of ART initiation; participants received 20 birr (∼1 USD) upon interview completion. Interview data were linked to an existing database that captured routinely collected clinical data on patients from the date of their enrollment in that clinic (or the date of their HIV-positive test if done at that clinic) up to 12 months after ART initiation. Data were deidentified before analysis. Ethical approval was obtained from the Oromia Regional Health Bureau, Columbia University, and the City University of New York.

Back to Top | Article Outline

Measures

Exposures

Internalized Stigma

Internalized stigma was assessed with the 5-item negative self-perception subscale of the HIV/AIDS Stigma Instrument, PLWHA (HASI-P),31 developed in sub-Saharan Africa. Items inquired how often over the previous 3 months participants, for example, felt that you did not deserve to live, that you were no longer a person, with response options ranging from Never (4) to Most of the time (1) An additional item not from this scale (You thought someone had cursed you) also was included (Cronbach's alpha = 0.95). Scores were recoded so that higher scores represented higher internalized stigma. Because summary responses were skewed (mean = 1.55, median = 1.33), we categorized them into tertiles.

Back to Top | Article Outline
Anticipated Stigma

Anticipated stigma was assessed with 12 items following the concept described by Earnshaw and Chaudoir,24 using the stem, Do you think the following could happen if others know or suspect you are HIV-positive (eg, your partner might get violent; your children might be abused or discriminated against; family members might treat you differently), with yes/no response options (Cronbach's alpha = 0.76). A total anticipated stigma score was constructed as the proportion of endorsed items from among all questions the participant was eligible to answer (ie, participants without children or without a partner were not eligible to answer those items), and the score was categorized into tertiles.

Back to Top | Article Outline
Enacted Stigma

Enacted stigma was measured with 9 items selected from HASI-P31 subscales (verbal abuse, fear of contagion, and social isolation); items inquired how often in the prior 3 months the participant had experienced rejection because of his/her HIV status (eg, You were told that you have no future, You were told that God is punishing you, Someone stopped being your friend), with response options ranging from Never (4) to Most of the time (1) (Cronbach's alpha = 0.99). Because the reported occurrence of all items was low, the summary measure was re-coded as any vs. none.

Back to Top | Article Outline

HIV Care Continuum Outcomes

Outcomes included 6 care-related indicators that were ascertained in the study and thought potentially to be influenced by stigma: (1) a repeat HIV+ test before enrolling in care, a possible indicator of delayed enrollment; (2) provider- vs. self-initiated testing, a possible indicator of delayed diagnosis; (3) a missed clinic visit before ART initiation; (4) eagerness vs. reluctance to initiate ART; (5) late ART initiation (initiating ART with advanced disease); and (6) ≥3-month gap in care after ART initiation.

By interview, participants were asked the date of their most recent HIV-positive test, and if they had previously tested HIV-positive; those who did were characterized as having a repeat HIV-positive test. For this variable, we excluded 349 participants for whom it was not possible to determine which test occurred first or if they reported a test date after their HIV clinic enrollment date. To determine who initiated testing, participants were asked if they sought the test on their own, or it was offered by a provider including as part of PMTCT services. They were additionally asked if they had missed a clinic visit before initiating ART (ever/never), and about their eagerness to start ART [5 response options dichotomized into (somewhat/very eager) vs. (somewhat/very reluctant or neither reluctant nor eager)]. Outcomes ascertained from electronic medical record data were late ART initiation, defined as CD4+ count <150 cells/μL or WHO stage IV at ART initiation,30 and a gap in HIV care of 3 months or more in the year after ART initiation. Participants (N = 146) who had no opportunity to experience a 3-month gap in care because they were lost to follow-up, transferred out, or had died before 3 months on ART were excluded from this variable.

Back to Top | Article Outline

Potential Confounders

Time from diagnosis in months was ascertained from the earliest self-reported date of HIV-positive test or the diagnosis date noted in the medical record to date of interview. Other measures examined as potential confounders were age, gender, education, religion, relationship status, widowhood, residence location (rural/urban), employment status, and food insecurity.

Back to Top | Article Outline

Statistical Analyses

Pairwise correlations between stigma domain measures were assessed with Spearman correlation coefficients. Bivariate associations between stigma and potential confounders were evaluated using χ2 statistics for categorical variables, and Mann-Whitney U and Kruskal Wallis tests for skewed continuous data. Logistic regression was used to model change in the log odds of each care continuum outcome associated with high and medium vs. low stigma in each domain (or any vs. no enacted stigma). Time from diagnosis was included a priori as a confounder because it could be associated with lower stigma and poorer care continuum outcomes. Other potential confounders that were significantly associated with stigma and altered the crude estimate of association were retained in the adjusted models.

Back to Top | Article Outline

RESULTS

Description of the Population

Of 1180 study participants, clinical data for up to 1 year following ART initiation was available for 1179. As described above, 831 were available for analysis of repeat HIV-positive testing, and 1033 participants were available for analysis of a 3-month gap in care following ART initiation. Among the 1180, mean age was 34 years, interquartile range (IQR) 28–40; the median length of time since diagnosis was 8.3 months (IQR: 1.1 months–3.4 years). Median time since enrollment in care was 2.9 months (IQR: 15 days–2.6 years). Other sample characteristics are shown in Table 1.

TABLE 1

TABLE 1

The mean internalized stigma score was 1.55 (SD: 0.57); the median was 1.33 (IQR: 1-2) (possible range: 1–4) (Table 1). The mean anticipated stigma score was 26.9 (SD: 22.60); the median was 22.22 (IQR: 9.09–44.44) (possible range: 1–100), indicating that, on average, individuals endorsed approximately one-quarter of possible anticipated stigma concerns. The most frequently cited concerns were people might start gossiping about you (62.0%) and your children might become upset or fearful (52.2%) (data not shown). Experiencing any enacted stigma in the past 3 months was reported by 16.3% of participants. Internalized stigma was correlated with both anticipated (rho = 0.422, P < 0.0001) and enacted stigma (rho = 0.196; P < 0.0001), but anticipated and enacted stigma were not significantly correlated (rho = 0.040, P= 0.1651) (data not shown).

Back to Top | Article Outline

Stigma and Care Continuum Outcomes

Internalized Stigma

High vs. low internalized stigma was significantly associated with higher odds of having had more than 1 HIV-positive test (vs. 1 HIV-positive test) [adjusted odds ratio (aOR): 1.8; 95% CI: 1.1 to 3.1]; higher odds of provider-(vs. self-) initiated testing (aOR: 1.7; 95% CI: 1.3 to 2.2); and lower odds of a missed visit (vs. none) (aOR: 0.63; 95% CI: 0.40 to 0.98) (Table 2). Internalized stigma was not associated with late ART initiation, eagerness to begin ART, or a 3-month gap in care.

TABLE 2

TABLE 2

Back to Top | Article Outline

Anticipated Stigma

Higher levels of anticipated stigma were significantly associated with higher odds of a repeat HIV-positive test (vs. 1 HIV-positive test) (aORmedium vs. low: 1.9; 95% CI: 1.1 to 3.2); and lower odds of being eager (vs. reluctant) to begin ART (aORhigh vs. low: 0.55; 95% CI: 0.35 to 0.87; aORmedium vs. low: 0.45; 95% CI: 0.30 to 0.69). Anticipated stigma was not associated with provider- vs. self-initiated test, a missed visit before ART initiation, late ART initiation, or a 3-month gap in care following ART initiation.

Back to Top | Article Outline

Enacted Stigma

Experiencing any vs. no enacted stigma was significantly associated with higher odds of a repeat HIV-positive test (vs. 1 HIV-positive test) (aOR: 1.9; 95% CI: 1.1 to 3.2), and higher odds of a missed visit before ART initiation (aOR: 1.8; 95% CI: 1.2 to 2.8). Enacted stigma was not associated with any of the other outcomes.

Back to Top | Article Outline

DISCUSSION

In a large population of PLWH initiating ART in Ethiopia, measures of internalized, anticipated, and enacted stigma were associated with several outcomes across the HIV care continuum: high internalized stigma with a provider-vs. a self-initiated HIV-test, possibly indicating delayed testing; higher internalized and anticipated stigma with repeat testing after an HIV-positive result, possibly indicating delayed enrollment in care; higher anticipated stigma with reluctance to initiate ART; and enacted stigma with missing a clinic visit before ART initiation.

These findings support emerging evidence that beyond reducing ART adherence, stigma influences other care continuum outcomes. Although data were collected before the most recent expansion of ART access, the study encompassed a period of expanding access.30 A limitation is that temporality cannot be established for the associations of stigma with repeat testing and provider-vs. self-initiated testing, as these outcomes were ascertained concurrently with stigma but they occurred earlier. Additionally, repeat testing and provider-initiated testing are only potential indicators of delayed testing and delayed enrollment in care. It is notable, however, that higher anticipated stigma, assessed close in time to ART initiation, was associated with greater reluctance to initiate. We are unsure why no stigma measure was associated with late ART initiation, but this outcome has multiple causes.30 Finally, the population in this study was restricted to those initiating ART, thereby excluding those lost at earlier stages of the care continuum. Overall, scores on stigma measures were low, especially enacted stigma, for which only 16% of participants reported an event. Although internalized and enacted stigma were assessed with reliable scales developed in sub-Saharan Africa,31 they may lack sensitivity for some outcomes. Further, anticipated stigma was newly developed and had acceptable but lower internal consistency reliability (α = 0.76) than the other stigma measures.

Despite these limitations, our study had several strengths: the large sample size, the distinct domains of stigma assessed, and the range of outcomes examined. The findings provide further support for the importance of investigating and addressing stigma across the entire HIV care continuum, especially given the need for effective stigma reduction interventions.32,33 Future research should examine care continuum outcomes before ART initiation, refine the anticipated stigma measure, and assess specific hypotheses about the association of each measure with important HIV care continuum outcomes prospectively, or in the context of an intervention.

Back to Top | Article Outline

REFERENCES

1. Mahajan AP, Sayles JN, Patel VA, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(suppl 2):S67–S79.
2. Grossman CI, Stangl AL. Editorial: Global action to reduce HIV stigma and discrimination. J Int AIDS Soc. 2013;16(3 suppl 2):18881.
3. Liu H, Hu Z, Li X, et al. Understanding interrelationships among HIV-related stigma, concern about HIV infection, and intent to disclose HIV serostatus: a pretest-posttest study in a rural area of eastern China. AIDS Patient Care STDS. 2006;20:133–142.
4. Simbayi LC, Kalichman SC, Strebel A, et al. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect. 2007;83:29–34.
5. Tsai AC, Bangsberg DR, Kegeles SM, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013;46:285–294.
6. Clark HJ, Lindner G, Armistead L, et al. Stigma, disclosure, and psychological functioning among HIV-infected and non-infected African-American women. Women Health. 2003;38:57–71.
7. Simbayi LC, Kalichman S, Strebel A, et al. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Social Sci Med. 2007;64:1823–1831.
8. Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one's HIV-positive status, stigma and social support. AIDS Care. 2008;20:1266–1275.
9. Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care. 2009;21:742–753.
10. Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect. 2003;79:442–447.
11. Genberg BL, Hlavka Z, Konda KA, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Social Sci Med. 2009;68:2279–2287.
12. Turan JM, Bukusi EA, Onono M, et al. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav. 2011;15:1111–1120.
13. Mall S, Middelkoop K, Mark D, et al. Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: the results of two consecutive community surveys conducted in the Western Cape, South Africa. AIDS Care. 2013;25:194–201.
14. Meiberg AE, Bos AE, Onya HE, et al. Fear of stigmatization as barrier to voluntary HIV counselling and testing in South Africa. East Afr J Public Health. 2008;5:49–54.
15. Treves-Kagan S, El Ayadi AM, Pettifor A, et al. Gender, HIV testing and stigma: the association of HIV testing behaviors and community-level and individual-level stigma in rural South Africa differ for men and women. AIDS Behav. 2017;21:2579–2588.
16. Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 suppl 2):18640.
17. Fox MP, Mazimba A, Seidenberg P, et al. Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART. J Int AIDS Soc. 2010;13:8.
18. Naar-King S, Bradford J, Coleman S, et al. Retention in care of persons newly diagnosed with HIV: outcomes of the Outreach Initiative. AIDS Patient Care STDS. 2007;21(suppl 1):S40–S48.
19. Vanable PA, Carey MP, Blair DC, et al. Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS Behav. 2006;10:473–482.
20. Kinsler JJ, Wong MD, Sayles JN, et al. The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDS. 2007;21:584–592.
21. Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Res Ther. 2011;8:8.
22. Hatcher AM, Turan JM, Leslie HH, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2012;16:1295–1307.
23. Williams LD. Understanding the relationships among HIV/AIDS-related stigma, health service utilization, and HIV prevalence and incidence in Sub-Saharan Africa: a multi-level theoretical perspective. Am J Community Psychol. 2014;53:146–158.
24. Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13:1160–1177.
25. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8:e1001056.
26. Clouse K, Pettifor AE, Maskew M, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013;62:e39–e46.
27. Lahuerta M, Ue F, Hoffman S, et al. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved 2013;24:359–383.
28. Joint United Nations Programme on HIV/AIDS (UNAIDS). The Gap Report. Geneva, Switzerland: UNAIDS; 2014.
29. Central Statistical Agency [Ethiopia] and ICF International. Ethiopia Demographic and Health Survey 2011. Addis Ababa, Ethiopia: Central Statistical Agency and ICF International; 2012.
30. Nash D, Tymejczyk O, Gadisa T, et al. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc. 2016;19:20637.
31. Holzemer WL, Uys LR, Chirwa ML, et al. Validation of the HIV/AIDS stigma Instrument—PLWA (HASI-P). AIDS Care. 2007;19:1002–1012.
32. Stangl Anne FLJK, Brady Laura M, Holland Claire E, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(suppl 2):18734.
33. Mak WWS, Mo PKH, Ma GYK, et al. Meta-analysis and systematic review of studies on the effectiveness of HIV stigma reduction programs. Social Sci Med. 2017;188:30–40.
Keywords:

delayed testing; delayed linkage to care; late ART initiation; retention in care

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.